Get started
Author

Anne-Marie Byrne

Observed names: A Byrne, A M Byrne, A. M. Byrne, A.-M. Byrne, Anne Marie Byrne
ORCID: 0000-0002-9030-8783
Observed ORCID: 0000-0002-9030-8783
OpenAlex ID: A5048684667
Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
2005 · Anne Marie Byrne, D.J. Bouchier-Hayes, et al. · Journal of Cellular and Molecular Medicine · 756
PDF
Lipopolysaccharide‐induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion
2002 · Judith H. Harmey, Corazon D. Bucana, et al. · International Journal of Cancer · 254
PDF
A peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cells
2005 · M P Barr, A M Byrne, et al. · British Journal of Cancer · 129
PDF
Ursodeoxycholic Acid Amides As Novel Glucocorticoid Receptor Modulators
2010 · Ruchika Sharma, David Prichard, et al. · Journal of Medicinal Chemistry · 36
Deoxycholic acid impairs glycosylation and fucosylation processes in esophageal epithelial cells
2012 · A.-M. Byrne, R. Sharma, et al. · Glycobiology · 24
PDF
Bile acids modulate the Golgi membrane fission process via a protein kinase Cη and protein kinase D-dependent pathway in colonic epithelial cells
2010 · Anne-Marie Byrne, Eilis Foran, et al. · Carcinogenesis · 24
PDF
Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett's oesophagus by modulating integrin‐αv trafficking
2017 · David O. Prichard, Anne Marie Byrne, et al. · Journal of Cellular and Molecular Medicine · 21
PDF
Unconjugated secondary bile acids activate the unfolded protein response and induce golgi fragmentation via a src-kinase-dependant mechanism
2016 · Ruchika Sharma, Francis Quilty, et al. · Oncotarget · 20
PDF
Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion
2015 · Anne-Marie Byrne, Spiros Bekiaris, et al. · British Journal of Cancer · 20
PDF
A fluorescent analogue of tauroursodeoxycholic acid reduces ER stress and is cytoprotective
2016 · Jason Gavin, Fran Quilty, et al. · Bioorganic & Medicinal Chemistry Letters · 9
Systematic Review and Meta-analysis of Prophylactic Negative Pressure Wound Therapy Devices for Major Lower Extremity Amputations
2025 · Megan Power Foley, Ciara Fahey, et al. · European Journal of Vascular and Endovascular Surgery · 5
Prophylactic Incisional Negative Pressure wound therapy (NPWT) for major Amputations (PINTA): protocol for randomized controlled trial of single-use NPWT devices for closed-incision major lower extremity amputations
2025 · Megan Power Foley, Ciara Fahey, et al. · BJS Open
108 Teiripe Sa Bhaile Team (tsab): an Early Supported Discharge Service for Hip Fractures From an Acute Hospital
2022 · AG Cummiskey, A Byrne, et al. · Age and Ageing
PDF
Clinical Characteristics of Patients Hospitalized for Severe Covid19: Experience From St Vincent's Hospital, Sydney
2021 · Colin Tuft, DC Smith, et al. · Respirology
Dysregulation of the Protein Secretory Pathway in Oesophageal Cancer Progression
2013 · A M Byrne, D Kelleher, et al. · Gut
PDF
PWE-086 Ursodeoxycholic acid modulates the glucocorticoid receptor in oesophageal cells
2010 · D Prichard, R Sharma, et al. · Gut
The role of Neuropilin-1 in tumor cell chemo-resistance
2006 · Anne Marie Byrne, David Bouchier–Hayes, et al. · Cancer Research
Outcome Following Use of the “s” Quattro Dynamic External-fixation Device in the Management of Fractures of the First Ray.
2005 · Anne Marie Byrne, SR Kearns, et al. · Orthopaedic Proceedings
The anti-tumour effects of chemo/radiotherapy are potentiated by cyclo-oxygenase-2 inhibition
2002 · G. Roche-Nagle, J. H. Harmey, et al. · Irish Journal of Medical Science (1971 -)
Cyclo-oxygenase 2 inhibition potentiates anti-tumour effects of chemo/radiotherapy
2002 · G. Roche-Nagle, J. H. Harmey, et al. · Irish Journal of Medical Science (1971 -)
Works count: 20
Citation count: 1,298
H-index: 9
I10-index: 9
Year
Topic
Type